跳至主要内容
临床试验/NCT00940797
NCT00940797已完成2 期

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients by Glucose CLAMP Technique

Laboratorios Silanes S.A. de C.V.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Insulin sensitivity

研究概览

简要总结

The aim of this study is to determine the effect of DMMET-01 on insulin sensitivity by Glucose CLAMP technique in Mexican type 2 diabetes patients, after 2 months of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ages eligible for study: 40 to 60 years
  • With type 2 diabetes evolution < 5 years without pharmacological treatment 1 month prior to the screening
  • Fasting glucose = 130-200 mg/dL
  • AIc of 7% to 9%
  • Blood pressure < 140/80 mmHg
  • Ability to communicate and meet the requirements of the study
  • Signed Written Informed Consent before to conducting any study
  • Body mass index (BMI) of 25 kg/m2 to 35 Kg/m2

排除标准

  • Suspected or confirmed pregnancy
  • Inability to secure the non-pregnant during the study duration
  • Hypersensitivity to any biguanides
  • Use of an investigational drug within 30 days prior to the screening
  • Liver failure, heart failure, kidney failure or thyroid disease
  • Periods of acute or chronic diarrhea or vomiting
  • Chronic hepatic disease
  • Total Cholesterol > 300 mg/dL
  • Triglycerides > 400 mg/dL

研究组 & 干预措施

DMMET-01

Experimental

干预措施: DMMET-01 (Drug)

Control

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Insulin sensitivity

时间窗: 2 months

次要结局

  • Insulin, fasting glucose, HbA1c(2 months)
  • Adverse Events(3 months)
  • Creatinine, Total Cholesterol, HDL, Triglycerides, Uric acid, AST, ALT, FA, DHL(2 months)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验